San Francisco Health Department issues alert on dangers of Xylazine after overdose deaths

A health alert from the San Francisco Health Department has raised concerns about the emerging dangers of Xylazine, commonly known as Tranq. This non-opioid veterinary tranquilizer, which is not approved for human use, has been found in the systems of individuals who died from drug overdoses in the city. The San Francisco Office of the Chief Medical Examiner reported that four overdose victims had low levels of Xylazine in their systems during a recent testing period from mid-December 2022 to mid-January 2023.

Xylazine is often mixed with potent drugs like fentanyl and heroin, heightening the risks associated with its use. While the presence of Xylazine in overdose cases is alarming, officials noted that there have been no reports of related skin wounds or evidence of injection use in San Francisco thus far. This suggests that the drug may not yet be widespread in the area.

In response to this potential threat, the Department of Public Health (DPH) is collaborating with city and community partners to gather more information and prepare street response teams. These teams will be trained to recognize the effects of Xylazine and respond effectively. Additionally, DPH is assessing the impact of Xylazine and exploring supportive care options, including treatment strategies for those affected.

As the situation develops, public health officials are committed to monitoring the situation closely and ensuring that the community is informed and prepared to address the challenges posed by this dangerous substance.